SMTL ID : 3b8q.1 (1 other biounit)

Crystal structure of the VEGFR2 kinase domain in complex with a naphthamide inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.75 Å

Oligo State

monomer

Ligands

1 x 900: N-(4-chlorophenyl)-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide(Non-covalent)

900.1: 17 residues within 4Å: Chain A: L.26, V.34, A.52, K.54, E.71, L.75, V.85, V.100, T.102, E.103, F.104, C.105, G.108, L.171, C.181, D.182, F.183 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:L.26, A:V.34, A:A.52, A:K.54, A:E.71, A:L.75, A:L.75, A:V.100, A:T.102, A:F.104, A:L.171, A:D.182 Hydrogen bonds: A:E.71, A:C.105, A:D.182 pi-Cation interactions: A:K.54

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Harmange, J.C. et al., Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis and Evaluation. J.Med.Chem. (2008)

Release Date

2008-04-01

Peptides

Vascular endothelial growth factor receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Vascular endothelial growth factor receptor 2

Related Entries With Identical Sequence